← All trials
NCT07223450
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 12, 2025
- Primary completion
- Oct 7, 2025
- Completion date
- Oct 7, 2025
- First posted
- Oct 31, 2025
- Last posted
- Oct 31, 2025
- Enrollment
- 8
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Institut Hospital del Mar d'Investigacions MèdiquesLead sponsor
- Food and Drug AdministrationCollaborator
- University of ManchesterCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.